Speaker illustration

Doctor Deniz Akdis

University Heart Center, Zurich (Switzerland)

Novel plasma biomarkers in arrhythmogenic cardiomyopathy: The role of ST2 and GDF-15 in predicting biventricular involvement

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Arrhythmogenic Right Ventricular Cardiomyopathy

Session: Ventricular Arrhythmias and Sudden Cardiac Death (SCD) ePosters

Thumbnail

Left ventricular dysfunction in arrhythmogenic cardiomyopathy: the influence of genotype, exercise and biomarkers

Event: EHRA 2019

Topic: Arrhythmogenic Right Ventricular Cardiomyopathy

Session: Ventricular Arrhythmias and Sudden Cardiac Death (SCD)

Thumbnail

Identification of novel biomarkers for diagnosis of arrhythmogenic right ventricular cardiomyopathy using transcriptomics and label-free proteomics

Event: ESC Congress 2018

Topic: Cardiomyopathies

Session: Novel molecular mechanisms in heart failure

Thumbnail

Sex hormones affect outcome in arrhythmogenic right ventricular cardiomyopathy/dysplasia: from a stem cell derived cardiomyocyte-based model to clinical biomarkers of disease outcome

Event: EHRA EUROPACE - CARDIOSTIM 2017

Topic: Clinical mechanisms (Cardiac arrhythmias, non invasive)

Session: Young Investigator Award: Basic and Translational Science

Thumbnail

Association between genotype and long-term outcome of ventricular involvement patterns in arrhythmogenic right ventricular cardiomyopathy/dysplasia

Event: EHRA EUROPACE - CARDIOSTIM 2017

Topic: Clinical mechanisms (Cardiac arrhythmias, non invasive)

Session: ECG and eCardiology

Thumbnail

Elevated testosterone serum levels contribute to adverse outcome in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia

Event: ESC CONGRESS 2016

Topic: Sudden death / resuscitation

Session: Sudden cardiac death

Thumbnail

This platform is supported by

logo Novo Nordisk